Skip to main content
Figure 9 | Virology Journal

Figure 9

From: Characterization of a branched lipopeptide candidate vaccine against influenza A/Puerto Rico 8/34 which is recognized by human B and T-cell immune responses

Figure 9

Average plaque count (after background subtraction, except the virus alone control which is shown directly as counted) of the sixteen donors against the sixteen synthetic influenza peptides and the included controls. The peptide that resulted in the largest change in plaque count as compared to the peptide-free control is bolded for each donor, and higher differences are highlighted (light grey if between 6 and 15 and dark grey if above 16).

Back to article page